Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2001
10/04/2001WO2001073439A1 Docosahexaenoic acid as retinoid x receptor and uses thereof
10/04/2001WO2001073438A1 Ricin inhibitors and methods for use thereof
10/04/2001WO2001073437A2 Antigen-specific enzyme-linked immunosorbent assay
10/04/2001WO2001073435A1 Methods for detecting inflammation and inflammatory conditions
10/04/2001WO2001073434A2 Identification of nuclear receptor-dependent coregulator recruitment
10/04/2001WO2001073433A2 Methods relating to self-interacting oligomeric complexes
10/04/2001WO2001073432A2 Method for detecting and/or quantifying first molecules
10/04/2001WO2001073431A2 Biomedical assay device
10/04/2001WO2001073430A2 Identification, assessment, prevention and therapy of cancers
10/04/2001WO2001073429A2 Detection of redox-active molecules in solution
10/04/2001WO2001073428A1 Method and system for clustering data
10/04/2001WO2001073426A2 Blood transfusion method and device
10/04/2001WO2001073424A1 Method and apparatus for the down-hole characterization of formation fluids
10/04/2001WO2001073420A1 Biosensor measuring device
10/04/2001WO2001073401A2 Molten metal inclusion sensor probes
10/04/2001WO2001073395A2 Method of preventing short sampling of a capillary or wicking fill device
10/04/2001WO2001073150A1 Scaffold-organized clusters and electronic devices made using such clusters
10/04/2001WO2001073133A1 Compositions and methods for identifying and targeting cancer cells
10/04/2001WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
10/04/2001WO2001073131A1 High specificity marker detection
10/04/2001WO2001073126A2 Diagnostic devices containing porous material
10/04/2001WO2001073125A2 High throughput screening array containing porous material
10/04/2001WO2001073124A2 Rapid response glucose sensor
10/04/2001WO2001073123A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/04/2001WO2001073120A1 Method of measuring polymorphism
10/04/2001WO2001073118A2 Hybridisation beacon and method of rapid sequence detection and discrimination
10/04/2001WO2001073117A1 Use of particles which have signal-emitting characteristics and at least one group with an affinity for marked nucleic acids
10/04/2001WO2001073115A1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors
10/04/2001WO2001073114A2 Reagents and methods for detecting a reduced cofactor
10/04/2001WO2001073110A1 Stabilization of highly sensitive nucleic acid stains in aqueous solutions
10/04/2001WO2001073109A2 Continuous process for manufacture of disposable electro-chemical sensor
10/04/2001WO2001073108A2 A bacterial two-hybrid system for protein interaction screening
10/04/2001WO2001073076A2 Helicase inhibitors
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001WO2001073030A2 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073028A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
10/04/2001WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter
10/04/2001WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001WO2001073015A1 Identification of human gaba transporter
10/04/2001WO2001073014A1 Human survivin interacting protein 1 (sip-1)
10/04/2001WO2001072995A2 Methods of producing a library and methods of selecting polynucletides
10/04/2001WO2001072977A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/04/2001WO2001072969A1 Effector-specific protein assembly and uses thereof
10/04/2001WO2001072962A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
10/04/2001WO2001072926A1 Trityl-type compounds and their use
10/04/2001WO2001072841A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072837A2 Methods of modulating drug clearance mechanisms by altering sxr activity
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072834A1 Selectable marker genes
10/04/2001WO2001072831A2 Immunoregulator
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001WO2001072782A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/04/2001WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer
10/04/2001WO2001072779A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
10/04/2001WO2001072778A2 Method of identifying inhibitors of tie-2
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same
10/04/2001WO2001072772A2 Calcium binding regulatory subunit
10/04/2001WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists
10/04/2001WO2001072766A1 Quality control reagents for nucleic acid microarrays
10/04/2001WO2001072680A1 Substituted chalcones as therapeutic compounds
10/04/2001WO2001072663A2 High density porous materials
10/04/2001WO2001072458A1 Site-specific, covalent bioconjugation of proteins
10/04/2001WO2001072392A2 New methods for separation and isolation of subpopulations of cells in biological samples
10/04/2001WO2001072342A1 Gastric emptying test-kit and method of testing gastric emptying of solid meal
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072302A1 Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists
10/04/2001WO2001072294A2 Method of treating hepatitis delta viral infection
10/04/2001WO2001072293A2 Antiprogestins with partial agonist activity
10/04/2001WO2001072225A1 A disposable lancet combined with a reagent carrying strip and a system for extracting and analysing blood in the body utilizing such a disposable lancet
10/04/2001WO2001072222A1 Non-invasive measurement of skin bilirubin level
10/04/2001WO2001072220A1 Method and device for sampling and analyzing interstitial fluid and whole blood samples
10/04/2001WO2001072214A1 Method and system for characterization and mapping of tissue lesions
10/04/2001WO2001072208A2 Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
10/04/2001WO2001072132A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof
10/04/2001WO2001036967A3 Aerosol can content analyzer workstation
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/04/2001WO2001032685A3 Gene expression directed by a super-psa promoter
10/04/2001WO2001032070A3 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease
10/04/2001WO2001022741A3 Medical applications of orthogonal polarization spectral imaging
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001021136A3 Compositions and methods for improved detection and classification of neoplasms
10/04/2001WO2001020335A3 Methods for modulating cell proliferation
10/04/2001WO2001019862A3 Polypeptides from moraxella (branhamella) catarrhalis
10/04/2001WO2001016369A3 Uv excitable fluorescent energy transfer dyes
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001012778A3 Flocculation of cell material
10/04/2001WO2001011047A3 Dna sequences isolated from human colonic epithelial cells
10/04/2001WO2001009041A3 System for protection of building water supplies against chemical and biological warfare agents
10/04/2001WO2001004361A3 Detection of hiv-1 by nucleic acid amplification
10/04/2001WO2000077120A3 Predicting proximity to coke formation
10/04/2001WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
10/04/2001WO2000051632A3 COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE
1 ... 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 ... 3937